Information Provided By:
Fly News Breaks for June 14, 2017
BIIB, ALXN
Jun 14, 2017 | 07:40 EDT
UBS analyst Martin Auster noted Alexion (ALXN) hired Biogen's (BIIB) Paul Clancy as CFO and believes it has a positive read-through as he is well known by the Street and is received favorably. The analyst also believes the company can restore value through a combination of execution on growth drivers and a reduction of its implied risk premium in light of recent regulatory headwinds. Auster reiterated his Buy rating and $140 price target on Alexion shares.
News For ALXN;BIIB From the Last 2 Days
There are no results for your query ALXN;BIIB